Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T33946 |
PF-06439015 mesylate
PF 06439015,PF-06439015,PF06439015 |
||
PF-06439015 overcomes clinical ALK (receptor tyrosine kinase anatropic lymphoma kinase) mutations resistant to krizotinib. Pf-06439015 is an effective selective inhibitor. |